Alvotech (ALVO) Stock Forecast: StockMap's 2-Week Call
ALVO stock forecast: StockMap's model makes no two-week call on Alvotech after the Nov 19 close: its evidence is split, 7 reasons for and 8 against. Too few two-week windows graded to judge yet.
Alvotech last closed at $4.29, -5.71% on the session.
Against the IVW growth benchmark the position is -3.38% over the forecast window.
Alvotech's market cap is $1.53B as of November 19, 2026.
No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -3 (too close to call).
Where ALVO sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 7 bullish and 8 bearish.
Agreement across those insights is 53%.
1 daily call for ALVO so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Alvotech in the 96th percentile on return on equity, where 100 is best.
Alvotech is classified under Health Care / Biotechnology.
StockMap tracks Alvotech as the 101st largest of the 394 companies it covers in the Biotechnology industry, part of the Health Care sector.
Across that group the current two-week reads are 200 Moderate Underperform, 134 Neutral, 43 Strong Underperform and 17 Moderate Outperform.
On that composite Alvotech ranks 71st of 394 in the group, against a group median of -0.27.